Skip to main content

Susan Kay Murphy, PhD

Property title
Associate Professor in Obstetrics and Gynecology
Campus Mail: 226 B Wing LSRC, 450 Research Drive, Durham, NC 27708
Phone: (919) 681-3423
Email: susan.murphy@duke.edu

Ovarian and cervical cancer epigenetics, imprinted genes in ovarian and cervical cancers, identification of methylation biomarkers of disease, ovarian cancer stem cells, chemotherapeutic response in ovarian cancer, tumor dormancy, the influence of the in utero environment on DNA methylation and risk of disease.

Education and Training

  • Ph.D., Wake Forest University, 1998
  • B.A., University of North Carolina at Charlotte, 1992

Selected Grants and Awards

Publications

Bernardini, MQ, Baba, T, Lee, PS, Barnett, JC, Sfakianos, GP, Secord, AA, Murphy, SK, Iversen, E, Marks, JR, and Berchuck, A. "Expression signatures of TP53 mutations in serous ovarian cancers. (Published online)" BMC Cancer 10 (May 26, 2010): 237-.

Full Text

Kondoh, E, Mori, S, Yamaguchi, K, Baba, T, Matsumura, N, Cory Barnett, J, Whitaker, RS, Konishi, I, Fujii, S, Berchuck, A, and Murphy, SK. "Targeting slow-proliferating ovarian cancer cells." Int J Cancer 126, no. 10 (May 15, 2010): 2448-2456.

Full Text

Yamaguchi, K, Mandai, M, Oura, T, Matsumura, N, Hamanishi, J, Baba, T, Matsui, S, Murphy, SK, and Konishi, I. "Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes." Oncogene 29, no. 12 (March 25, 2010): 1741-1752.

Full Text

Lee, PS, Teaberry, VS, Bland, AE, Huang, Z, Whitaker, RS, Baba, T, Fujii, S, Secord, AA, Berchuck, A, and Murphy, SK. "Elevated MAL expression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancer." Int J Cancer 126, no. 6 (March 15, 2010): 1378-1389.

Full Text

Barnett, JC, Bean, SM, Whitaker, RS, Kondoh, E, Baba, T, Fujii, S, Marks, JR, Dressman, HK, Murphy, SK, and Berchuck, A. "Ovarian cancer tumor infiltrating T-regulatory (T(reg)) cells are associated with a metastatic phenotype." Gynecol Oncol 116, no. 3 (March 2010): 556-562.

Full Text

Murphy, SK. "Targeting ovarian cancer-initiating cells." Anticancer Agents Med Chem 10, no. 2 (February 2010): 157-163. (Review)

Scholars@Duke

Barnett, JC, Bean, SM, Nakayama, JM, Kondoh, E, Murphy, SK, and Berchuck, A. "High poly(adenosine diphosphate-ribose) polymerase expression and poor survival in advanced-stage serous ovarian cancer." Obstet Gynecol 115, no. 1 (January 2010): 49-54.

Full Text

Hoyo, C, Schildkraut, JM, Murphy, SK, Chow, W-H, Vaughan, TL, Risch, H, Marks, JR, Jirtle, RL, Calingaert, B, Mayne, S, Fraumeni, J, and Gammon, MD. "IGF2R polymorphisms and risk of esophageal and gastric adenocarcinomas." Int J Cancer 125, no. 11 (December 1, 2009): 2673-2678.

Full Text

Gregory, SG, Connelly, JJ, Towers, AJ, Johnson, J, Biscocho, D, Markunas, CA, Lintas, C, Abramson, RK, Wright, HH, Ellis, P, Langford, CF, Worley, G, Delong, GR, Murphy, SK, Cuccaro, ML, Persico, A, and Pericak-Vance, MA. "Genomic and epigenetic evidence for oxytocin receptor deficiency in autism. (Published online)" BMC Med 7 (October 22, 2009): 62-.

Full Text

Hoyo, C, Murphy, SK, and Jirtle, RL. "Imprint regulatory elements as epigenetic biosensors of exposure in epidemiological studies." J Epidemiol Community Health 63, no. 9 (September 2009): 683-684.

Full Text

Pages